Kaya Holdings (KAYS) Non-Current Debt (2012 - 2025)
Kaya Holdings (KAYS) recorded quarterly Non-Current Debt of $250000.0 in Q2 2025, little changed quarter-over-quarter from $250000.0 in Q1 2025, and down 50.0% on a YoY basis from $500000.0 in Q2 2024.
Kaya Holdings (KAYS) Non-Current Debt (2012 - 2025) Analysis & Trends
Kaya Holdings' Non-Current Debt history runs 14 years deep, the most recent figure standing at $250000.0 for Q2 2025.
- In Q2 2025, Non-Current Debt fell 50.0% year-over-year to $250000.0; the TTM figure through Jun 2025 stood at $250000.0 (down 50.0% YoY), while the FY2024 annual figure was $61608.0, down 75.36% from the prior year.
- Non-Current Debt was $250000.0 for Q2 2025 at Kaya Holdings, roughly flat from $250000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $7.5 million in Q1 2024 to a low of $9312.0 in Q2 2023.
- Historically, Non-Current Debt has averaged $1.8 million across 5 years, with a median of $250000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt surged 5269.42% in 2024, then slumped 96.68% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $6.9 million in 2021, then gained by 3.53% to $7.2 million in 2022, then plunged by 96.52% to $250000.0 in 2023, then tumbled by 75.36% to $61608.0 in 2024, then jumped by 305.79% to $250000.0 in 2025.
- The last three Non-Current Debt figures came in at $250000.0 (Q2 2025), $250000.0 (Q1 2025), and $61608.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Kaya Holdings | - | - | 5,370.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 250,000.00 |
| Jun 30, 2025 | 250,000.00 |
| Mar 31, 2025 | 250,000.00 |
| Mar 31, 2025 | 250,000.00 |
| Dec 31, 2024 | 61,608.00 |
| Dec 31, 2024 | 61,608.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 7.54 Mn |
| Mar 31, 2024 | 7.54 Mn |
| Dec 31, 2023 | 250,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | 355,000.00 |
| Sep 30, 2023 | 355,000.00 |
| Jun 30, 2023 | 9,312.00 |
| Jun 30, 2023 | 9,312.00 |
| Dec 31, 2022 | 7.18 Mn |
| Dec 31, 2022 | 7.18 Mn |